Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

After upstream bioprocessing, such as developing a cell line or microorganism that can produce an intended product, a bioprocessor turns to downstream steps to capture and purify that product, as well ...

Raising productivity and quality is the top priority when manufacturers of all sectors endeavor to boost revenue and competitiveness. To manufacturers, whether in traditional manufacturing or ...

Although the medical device industry has seen nothing but growth over the past few decades, that same growth has been ...